Found 5 results

Name Type of Offering Accepted Date
Eleven Biotherapeutics, Inc. See All Filings
D 2010-02-22
Amount To Be Raised $35,000,000
Associated Brokers / Dealers N/A
CIK Number 0001485003
Filed Document 0001485003-10-000001
Exclusions or Exemptions N/A
Accepted Date 2010-02-22
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Eleven Biotherapeutics, Inc. See All Filings
D/A 2010-10-08
Amount To Be Raised $35,000,000
Associated Brokers / Dealers N/A
CIK Number 0001485003
Filed Document 0001485003-10-000003
Exclusions or Exemptions N/A
Accepted Date 2010-10-08
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Eleven Biotherapeutics, Inc. See All Filings
D 2014-12-05
Amount To Be Raised $20,000,010
Associated Brokers / Dealers N/A
CIK Number 0001485003
Filed Document 0001485003-14-000002
Exclusions or Exemptions 506b
Accepted Date 2014-12-05
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Eleven Biotherapeutics, Inc. See All Filings
D 2016-09-28 10:41:01
Amount To Be Raised $13,525,262
Associated Brokers / Dealers N/A
CIK Number 0001485003
Filed Document 0001485003-16-000183
Exclusions or Exemptions 506b
Accepted Date 2016-09-28 10:41:01
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Eleven Biotherapeutics, Inc. See All Filings
D 2018-04-05 11:22:13
Amount To Be Raised $996,016
Associated Brokers / Dealers N/A
CIK Number 0001485003
Filed Document 0001140361-18-017371
Exclusions or Exemptions 506b
Accepted Date 2018-04-05 11:22:13
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity